C. Alvarez

发表

Treatment with aliskiren/amlodipine combination in patients with moderate‐to‐severe hypertension: a randomised, double‐blind, active comparator trial

D. Häring, R. Braun-Dullaeus, S. Shustov, 2012, International journal of clinical practice.

Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

M. Uder, A. Cremer, P. Gosse, 2021, The Lancet.

Effect of CYP3A4, CYP3A5, MDR1 and POR Genetic Polymorphisms in Immunosuppressive Treatment in Chilean Kidney Transplanted Patients

L. Quiñones, Jana Stojanova, S. Mezzano, 2021, Frontiers in Pharmacology.

Calcium channel blockers and early cyclosporine nephrotoxicity after renal transplantation: a prospective randomized study.

L. Ruilope, J. Morales, M. Praga, 1990, Transplantation proceedings.

FIRST-LINE TREATMENT WITH ALISKIREN/AMLODIPINE COMBINATION PROVIDES ROBUST BLOOD PRESSURE REDUCTIONS IN PATIENTS WITH SEVERE HYPERTENSION: 9A.06

D. Häring, R. Braun-Dullaeus, S. Shustov, 2010 .

Treatment with aliskiren/amlodipine combination in patients with moderate‐to‐severe hypertension: a randomised, double‐blind, active comparator trial

R. Braun-Dullaeus, C. Alvarez, J. Zhang, 2012, International journal of clinical practice.